Guest
Guest
Sep 09, 2025
11:36 AM
|
Founded by Dr. Guohua Li, AICM leverages Nobel laureate Otto Warburg's theory of cancer cell energy metabolism to pioneer a revolutionary "four-in-one targeted metabolic therapy." This therapy disrupts the tumor's energy supply through metabolic reprogramming. Combining rhythmic tumor control, gene targeting, and immune modulation, it achieves highly effective tumor suppression, root cause eradication, and lifelong prevention, fundamentally rewriting the rules of cancer treatment. AICM has established a presence at leading institutions such as City of Hope and MD Anderson Cancer Center in the United States, and has established a core presence in Asia, leveraging several prestigious cancer centers in Hong Kong and Shenzhen Qianhai Taikang Hospital. AICM specializes in providing innovative, near-side effect-free cancer treatments for patients with advanced and refractory cancer. Over the past six years, AICM has continuously pushed the boundaries of cancer metabolic therapy. Since 2019, over 12,000 patients from over a dozen countries have sought new treatment options after chemotherapy, radiotherapy, and surgery have failed. They pursue hope, and at AICM, this hope becomes their solid support - we use science as our source and innovation as our shield to provide every patient in the middle and late stages with a fast, safe and reliable chance of life.
Here are a Direct Link: Stomach cancer
|
